Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2a Multicenter Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors

NCT04957290 is registered in ClinicalTrials.gov with Noxopharm Limited as lead sponsor.

NCT NCT04957290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04957290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2a Multicenter Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors
Lead sponsor
Noxopharm Limited
Phase
Phase 1/2
Overall status
Terminated
Start date
October 25, 2021
Completion date
June 7, 2023
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer and other solid tumors